Refractory Microsatellite Stable Metastatic Colorectal Cancer with ERBB2/ERBB3 Mutation May Be Preferred Population for Regorafenib Plus PD-1 Inhibitor Therapy: a Real-World Study.
FRONTIERS IN ONCOLOGY（2023）
Key words
colorectal cancer,immune checkpoint inhibitor,microsatellite stable,regorafenib,ErbB
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined